PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19949857-6	2010	Cox proportional hazards analysis was applied to determine hazard ratios in quintiles of dietary acrylamide intake stratifying on estrogen receptor (ER) and progesterone receptor (PR) and smoking status.	Acrylamide	97-107	estrogen receptor 1	Homo sapiens	130-147	
29445914-0	2019	Interaction between dietary acrylamide intake and genetic variants for estrogen receptor-positive breast cancer risk.	Acrylamide	28-38	estrogen receptor 1	Homo sapiens	71-88	
29445914-1	2019	PURPOSE: The association between dietary acrylamide intake and estrogen receptor-positive (ER+) breast cancer risk in epidemiological studies is inconsistent.	Acrylamide	41-51	estrogen receptor 1	Homo sapiens	63-80	
19949857-6	2010	Cox proportional hazards analysis was applied to determine hazard ratios in quintiles of dietary acrylamide intake stratifying on estrogen receptor (ER) and progesterone receptor (PR) and smoking status.	Acrylamide	97-107	estrogen receptor 1	Homo sapiens	149-151	
19015201-4	2009	The multivariate rate ratios comparing extreme quartiles of acrylamide intake were 0.91 (95% confidence interval (CI): 0.80, 1.02) for overall breast cancer, 0.89 (95% CI: 0.74, 1.08) for ER+PR+ tumors, 1.17 (95% CI: 0.84, 1.64) for ER+PR- tumors, and 0.91 (95% CI: 0.61, 1.38) for ER-PR- tumors.	Acrylamide	60-70	estrogen receptor 1	Homo sapiens	188-190	
19015201-4	2009	The multivariate rate ratios comparing extreme quartiles of acrylamide intake were 0.91 (95% confidence interval (CI): 0.80, 1.02) for overall breast cancer, 0.89 (95% CI: 0.74, 1.08) for ER+PR+ tumors, 1.17 (95% CI: 0.84, 1.64) for ER+PR- tumors, and 0.91 (95% CI: 0.61, 1.38) for ER-PR- tumors.	Acrylamide	60-70	estrogen receptor 1	Homo sapiens	233-235	
19015201-4	2009	The multivariate rate ratios comparing extreme quartiles of acrylamide intake were 0.91 (95% confidence interval (CI): 0.80, 1.02) for overall breast cancer, 0.89 (95% CI: 0.74, 1.08) for ER+PR+ tumors, 1.17 (95% CI: 0.84, 1.64) for ER+PR- tumors, and 0.91 (95% CI: 0.61, 1.38) for ER-PR- tumors.	Acrylamide	60-70	estrogen receptor 1	Homo sapiens	233-235	
17033922-5	2007	The two analogs, which have an acrylamide or a methyl vinyl ketone replacing the acrylic acid group of GW7604, display lower binding affinity for ER alpha than GW7604, but show similar antagonism of estradiol-induced activation of ER alpha-mediated transcription as GW7604 and inhibit estradiol-induced proliferation of the MCF-7 cell line with a similar potency as GW7604.	Acrylamide	31-41	estrogen receptor 1	Homo sapiens	146-154